Psychiatry
RECOVER trial suggests vagus nerve stimulation benefits some patients with severe treatment-resistant depression for at least two years
AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨
An implanted device that stimulates the vagus nerve was associated with sustained improvements in symptoms, functioning and quality of life among adults with long-standing, treatment-resistant major depression, according to researchers reporting two-year follow-up data from the ongoing RECOVER study led by Washington University School of Medicine in St. Louis.
Carmen Prada, head of mental health at Córdoba's Hospital Reina Sofía, testified Thursday in court that her patient Francisco Miguel León Benítez had no suicidal intentions when he died in 2020. Prosecutors seek four years in prison, while the private accusation demands eight for two involuntary homicides, including that of a man the patient killed in 2015. The family accuses the doctor of failing to order involuntary commitment despite repeated requests since 2010.
AI에 의해 보고됨
Uppsala county's psychiatric ambulance, operating only eight hours a day, misses 60 to 80 percent of mental health alarms due to resource shortages. Hospital board chair Neil Ormerod (V) wants to extend operating hours but lacks funding. Police report a clear difference when the service is active.
A new psychiatric diagnosis aims to identify a forgotten patient group fearing they disgust others with their smell. This results in unnecessary washing of clean clothes. The condition, known as ORD, stems from a constant pursuit of freshness.
AI에 의해 보고됨
Scientists from Sweden, Denmark, and Germany have created a genetic test using polygenic risk scores to help predict which antidepressants and anti-anxiety medications will work best for individuals. The approach, tested on research databases, could reduce the trial-and-error process that affects nearly half of patients with depression or anxiety. Lead researcher Professor Fredrik Åhs envisions a future with cheap, effective tests to speed up relief for millions.